ADMA
Price
$8.21
Change
-$0.11 (-1.32%)
Updated
Jun 12 closing price
Capitalization
1.9B
59 days until earnings call
Intraday BUY SELL Signals
MAZE
Price
$24.05
Change
-$0.04 (-0.17%)
Updated
Jun 12 closing price
Capitalization
1.33B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADMA vs MAZE

Header iconADMA vs MAZE Comparison
Open Charts ADMA vs MAZEBanner chart's image
ADMA vs MAZE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADMA vs. MAZE commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a StrongBuy and MAZE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (ADMA: $8.21 vs. MAZE: $24.05)
Brand notoriety: ADMA and MAZE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 54% vs. MAZE: 90%
Market capitalization -- ADMA: $1.9B vs. MAZE: $1.33B
ADMA [@Biotechnology] is valued at $1.9B. MAZE’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 1 FA rating(s) are green whileMAZE’s FA Score has 1 green FA rating(s).

  • ADMA’s FA Score: 1 green, 4 red.
  • MAZE’s FA Score: 1 green, 4 red.
According to our system of comparison, MAZE is a better buy in the long-term than ADMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 5 TA indicator(s) are bullish while MAZE’s TA Score has 4 bullish TA indicator(s).

  • ADMA’s TA Score: 5 bullish, 3 bearish.
  • MAZE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ADMA is a better buy in the short-term than MAZE.

Price Growth

ADMA (@Biotechnology) experienced а +3.01% price change this week, while MAZE (@Biotechnology) price change was -0.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

ADMA is expected to report earnings on Aug 12, 2026.

MAZE is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($1.9B) has a higher market cap than MAZE($1.33B). MAZE has higher P/E ratio than ADMA: MAZE (191.34) vs ADMA (12.07). MAZE YTD gains are higher at: -41.950 vs. ADMA (-54.989). ADMA has higher annual earnings (EBITDA): 222M vs. MAZE (-131.29M). MAZE has more cash in the bank: 352M vs. ADMA (138M). MAZE has less debt than ADMA: MAZE (61.2M) vs ADMA (204M). ADMA has higher revenues than MAZE: ADMA (510M) vs MAZE (20M).
ADMAMAZEADMA / MAZE
Capitalization1.9B1.33B143%
EBITDA222M-131.29M-169%
Gain YTD-54.989-41.950131%
P/E Ratio12.07191.346%
Revenue510M20M2,550%
Total Cash138M352M39%
Total Debt204M61.2M333%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMAMAZE
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signal:
Gain/Loss:
MAZE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PTEU33.350.16
+0.48%
Pacer Trendpilot™ European ETF
BITO8.650.01
+0.12%
ProShares Bitcoin ETF
GJP24.23N/A
N/A
Synthetic Fixed Income Securities on the behalf of STRATS for Dominion Resources Series 2005-6
TEKY44.43N/A
N/A
Lazard Next Gen Technologies ETF
XTWY37.15-0.14
-0.38%
BondBloxx Bloomberg TwentyYrTrgDuUSTrETF

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with VCYT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-1.32%
VCYT - ADMA
36%
Loosely correlated
-0.19%
TRDA - ADMA
35%
Loosely correlated
+2.38%
AMRN - ADMA
34%
Loosely correlated
+2.28%
AGIO - ADMA
34%
Loosely correlated
+2.58%
AUPH - ADMA
34%
Loosely correlated
-0.19%
More

MAZE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
-0.17%
AVXL - MAZE
38%
Loosely correlated
N/A
PROK - MAZE
37%
Loosely correlated
-1.20%
IMNM - MAZE
34%
Loosely correlated
+0.11%
ADMA - MAZE
31%
Poorly correlated
-1.32%
BEAM - MAZE
29%
Poorly correlated
-1.29%
More